New cancer-fighting immunotherapy enters clinical trials

(Max Delbr ü ck Center for Molecular Medicine in the Helmholtz Association) Researchers from the MDC and Charit é have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells. The safety of the novel therapy is now being tested on patients with bone marrow cancer in a phase I clinical trial.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news